117 related articles for article (PubMed ID: 8813099)
21. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
[TBL] [Abstract][Full Text] [Related]
22. Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report.
Bessa O
Conn Med; 1995 Jun; 59(6):331. PubMed ID: 7648851
[No Abstract] [Full Text] [Related]
23. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
24. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K
Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671
[TBL] [Abstract][Full Text] [Related]
25. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
[TBL] [Abstract][Full Text] [Related]
26. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
28. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
Zinzani PL; Tani M; Marchi E; Stefoni V; Alinari L; Musuraca G; Gabriele A; Pileri S; Baccarani M
Haematologica; 2004 Mar; 89(3):309-13. PubMed ID: 15020269
[TBL] [Abstract][Full Text] [Related]
30. Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia.
Benz R; Stussi G; Fehr J
Br J Haematol; 2010 Feb; 148(4):664-5; author reply 665-6. PubMed ID: 19814738
[No Abstract] [Full Text] [Related]
31. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
Juliusson G; Liliemark J
Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
[TBL] [Abstract][Full Text] [Related]
32. Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.
Clavio M; Masoudi B; Spriano M; Casciaro S; Gobbi M; Damasio EE
Haematologica; 1999 May; 84(5):466-8. PubMed ID: 10329930
[No Abstract] [Full Text] [Related]
33. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674
[No Abstract] [Full Text] [Related]
34. [50-year-old man with weight loss and splenomegaly].
Austein T; Schmitt A
Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
[No Abstract] [Full Text] [Related]
35. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
36. Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadenosine for hairy cell leukemia.
Ilyas W; Myers D; Mann R; Seraly MP
J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):316-8. PubMed ID: 10426918
[TBL] [Abstract][Full Text] [Related]
37. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Koczwara B; Spangenthal E; Bernstein SH
Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
[TBL] [Abstract][Full Text] [Related]
38. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
Seshadri P
Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
[No Abstract] [Full Text] [Related]
39. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Góra-Tybor J; Robak T
Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
[TBL] [Abstract][Full Text] [Related]
40. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
